chr10-43100734-G-A

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS1

The NM_020975.6(RET):​c.337+12G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000446 in 1,581,418 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0018 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00030 ( 0 hom. )

Consequence

RET
NM_020975.6 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: -1.56

Publications

0 publications found
Variant links:
Genes affected
RET (HGNC:9967): (ret proto-oncogene) This gene encodes a transmembrane receptor and member of the tyrosine protein kinase family of proteins. Binding of ligands such as GDNF (glial cell-line derived neurotrophic factor) and other related proteins to the encoded receptor stimulates receptor dimerization and activation of downstream signaling pathways that play a role in cell differentiation, growth, migration and survival. The encoded receptor is important in development of the nervous system, and the development of organs and tissues derived from the neural crest. This proto-oncogene can undergo oncogenic activation through both cytogenetic rearrangement and activating point mutations. Mutations in this gene are associated with Hirschsprung disease and central hypoventilation syndrome and have been identified in patients with renal agenesis. [provided by RefSeq, Sep 2017]
RET Gene-Disease associations (from GenCC):
  • familial medullary thyroid carcinoma
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • multiple endocrine neoplasia type 2A
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, ClinGen, Orphanet
  • multiple endocrine neoplasia type 2B
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P, ClinGen
  • pheochromocytoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Hirschsprung disease, susceptibility to, 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Haddad syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Hirschsprung disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • renal agenesis, unilateral
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • bilateral renal agenesis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • renal agenesis
    Inheritance: AR Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 10-43100734-G-A is Benign according to our data. Variant chr10-43100734-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 299887.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00185 (281/152192) while in subpopulation AFR AF = 0.00624 (259/41538). AF 95% confidence interval is 0.00561. There are 1 homozygotes in GnomAd4. There are 147 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_020975.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RET
NM_020975.6
MANE Select
c.337+12G>A
intron
N/ANP_066124.1P07949-1
RET
NM_001406743.1
c.337+12G>A
intron
N/ANP_001393672.1P07949-1
RET
NM_001406744.1
c.337+12G>A
intron
N/ANP_001393673.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RET
ENST00000355710.8
TSL:5 MANE Select
c.337+12G>A
intron
N/AENSP00000347942.3P07949-1
RET
ENST00000340058.6
TSL:1
c.337+12G>A
intron
N/AENSP00000344798.4P07949-2
RET
ENST00000713926.1
c.337+12G>A
intron
N/AENSP00000519223.1A0AAQ5BH28

Frequencies

GnomAD3 genomes
AF:
0.00185
AC:
282
AN:
152074
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00628
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000524
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00240
GnomAD2 exomes
AF:
0.000464
AC:
89
AN:
191850
AF XY:
0.000377
show subpopulations
Gnomad AFR exome
AF:
0.00584
Gnomad AMR exome
AF:
0.000416
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000995
Gnomad OTH exome
AF:
0.000398
GnomAD4 exome
AF:
0.000297
AC:
425
AN:
1429226
Hom.:
0
Cov.:
43
AF XY:
0.000274
AC XY:
194
AN XY:
707774
show subpopulations
African (AFR)
AF:
0.00606
AC:
200
AN:
33016
American (AMR)
AF:
0.000424
AC:
17
AN:
40112
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25442
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38480
South Asian (SAS)
AF:
0.00
AC:
0
AN:
82086
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49686
Middle Eastern (MID)
AF:
0.00152
AC:
7
AN:
4600
European-Non Finnish (NFE)
AF:
0.000152
AC:
167
AN:
1096740
Other (OTH)
AF:
0.000576
AC:
34
AN:
59064
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
24
48
72
96
120
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00185
AC:
281
AN:
152192
Hom.:
1
Cov.:
33
AF XY:
0.00198
AC XY:
147
AN XY:
74394
show subpopulations
African (AFR)
AF:
0.00624
AC:
259
AN:
41538
American (AMR)
AF:
0.000523
AC:
8
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10596
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
67990
Other (OTH)
AF:
0.00238
AC:
5
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
13
26
38
51
64
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00154
Hom.:
0
Bravo
AF:
0.00223
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
-
2
not specified (2)
-
-
1
Hirschsprung Disease, Dominant (1)
-
-
1
Multiple endocrine neoplasia (1)
-
-
1
Multiple endocrine neoplasia type 2A (1)
-
-
1
Multiple endocrine neoplasia type 2B (1)
-
-
1
Multiple endocrine neoplasia, type 2 (1)
-
-
1
not provided (1)
-
-
1
Pheochromocytoma (1)
-
-
1
Renal hypodysplasia/aplasia 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
1.8
DANN
Benign
0.71
PhyloP100
-1.6
PromoterAI
-0.042
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200468424; hg19: chr10-43596182; API